Human clinical trials on molecules that directly activate sirtuins will resume soon, despite past scientific obstacles that had slowed the field.

noli's read

The central concept relies on sirtuins, a family of proteins involved in the regulation of cellular aging. While the role of sirtuins is well-documented in animal models (yeast, worms, mice) as potentially influencing metabolic health, their direct application in humans remains a subject of intense scientific debate. Research, including meta-analyses and studies published in journals such as 'Nature', highlights that the direct activation of these proteins is complex and that results obtained in animals do not always translate identically to humans. The historical controversy mentioned by the creator refers to past disagreements within the scientific community concerning the efficacy and mechanism of action of molecules like resveratrol. To date, there is no clinical consensus proving that a single molecule can 'activate' these pathways in a safe and effective way to prolong human lifespan. The field is therefore in an exploratory phase, where theoretical enthusiasm must still be validated by rigorous, large-scale randomized controlled trials (RCTs).

the sources

No named source held this one up — that absence is part of the verdict.